Clinical Study to Evaluate Efficacy and Safety of ASC and Fibringlue or Fibringlue in Patients With Crohn's Fistula
Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
This is a phase III study to evaluate the efficacy and safety of ASC(Autologous
Adipose-derived Stem Cells) and Fibringlue or Fibringlue in Patients With Crohn's Fistula.